Molecular diagnosis of antibody-mediated rejection in human kidney transplants

American Journal of Transplantation

Volumn 13, Issue 4, 2013, Pages 971-983

  Sellares J ^a,b   Reeve, J ^a,c   Loupy, A ^d   Mengel, M ^a,c   Sis, B ^c   Skene, A ^a,e   De Freitas, D G ^f   Kreepala, C ^a,f   Hidalgo, L G ^a,c   Famulski, K S ^a,c   Halloran, P F ^a,c,f  

^a UNIVERSITY OF ALBERTA   (Canada)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITY OF ALBERTA   (Canada)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e AUSTIN HOSPITAL   (Australia)

^f MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Antibody mediated rejection; classifier; kidney transplant; microarrays; molecular diagnostics

Indexed keywords

COMPLEMENT COMPONENT C4D; HLA ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY MEDIATED REJECTION; ARTICLE; CHILD; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GRAFT FAILURE; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; MOLECULAR DIAGNOSIS; NATURAL KILLER CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN MICROARRAY; SCHOOL CHILD; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; CHILD; CHILD, PRESCHOOL; COMPLEMENT C4B; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INTERFERON-GAMMA; KIDNEY TRANSPLANTATION; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDE FRAGMENTS; PROBABILITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 84875733309     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12150     Document Type: Article

References (63)

1. Loupy A, Hill GS, Jordan SC,. The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol 2012; 8: 348-357.
2. Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520-331.
3. Sellares J, De Freitas D, Mengel M, et al. Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and non-adherence. Am J Transplant 2012; 12: 388-399.
4. Gorer PA,. The detection of antigenic differences in mouse erythrocytes by the employment of immune sera. Br J Exp Pathol 1936; 17: 42-50.
5. Gorer PA,. The role of antibodies in immunity to transplanted leukemia in mice. J Pathol Bacteriol 1942; 54: 51-65.
6. Gorer PA, O'Gorman P,. The cytotoxic activity of isoantibodies in mice. Transplant Bull 1956; 3: 142-143.
7. Kissmeyer-Nielsen F, Olsen S, Peterson VP, Fjeldborg O,. Hyperacute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. Lancet 1966; 2: 662-665.
8. Starzl TE, Lerner RA, Dixon FJ, Groth CG, Brettschneider L, Terasaki PI,. Shwartzman reaction after human renal homotransplantation. N Engl J Med 1968; 278: 642-647.
9. Patel R, Terasaki PI,. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280: 735-780.
10. Terasaki PI,. Humoral theory of transplantation. Am J Transplant 2003; 3: 665-673. (Pubitemid 36745238)
11. Halloran PF, Wadgymar A, Ritchie S, Falk J, Solez K, Srinivasa NS,. The significance of the anti-class I antibody response. I: Clinical and pathologic features of anti-class I-mediated rejection. Transplant 1990; 49: 85-91. (Pubitemid 20051591)
12. Halloran PF, Schlaut J, Solez K, Srinivasa NS,. The significance of the anti-class I response II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplant 1992; 53: 550-555.
13. Trpkov K, Campbell P, Pazderka F, Cockfield S, Solez K, Halloran PF,. Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Transplant 1996; 61: 1586-1592. (Pubitemid 26190900)
14. Feucht HE, Felber E, Gokel MJ, et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 1991; 86: 464-470.
15. Feucht HE, Schneeberger H, Hillebrand G, et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43: 1333-1338. (Pubitemid 23161421)
16. Feucht HE,. Complement C4d in graft capillaries-the missing link in the recognition of humoral alloreactivity. Am J Transplant 2003; 3: 646-652. (Pubitemid 36745236)
17. Collins AB, Schneeberger EE, Pascual MA, et al. Complement activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999; 10: 2208-2214. (Pubitemid 29453499)
18. Loupy A, Suberbielle-Boissel C, Hill GS, et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009; 9: 2561-2570.
19. Cosio FG, Gloor JM, Sethi S, Stegall MD,. Transplant glomerulopathy. Am J Transplant 2008; 8: 492-496. (Pubitemid 351287536)
20. Loupy A, Hill GS, Suberbielle C, et al. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant 2011; 11: 56-65.
21. Mauiyyedi S, Pelle PD, Saidman S, et al. Chronic humoral rejection: Identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001; 12: 574-582. (Pubitemid 32180027)
22. Regele H, Bohmig GA, Habicht A, et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13: 2371-2380. (Pubitemid 34925248)
23. Sis B, Jhangri GS, Riopel J, et al. A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant 2012; 12: 1168-1179.
24. Furness PN, Taub N,. International variation in the interpretation of renal transplant biopsies: Report of the CERTPAP Project. Kidney Int 2001; 60: 1998-2012. (Pubitemid 33000007)
25. Furness PN, Taub N, Assmann KJ, et al. International variation in histologic grading is large, and persistent feedback does not improve reproducibility. Am J Surg Pathol 2003; 27: 805-810. (Pubitemid 36617518)
26. Gibson IW, Gwinner W, Brocker V, et al. Peritubular capillaritis in renal allografts: Prevalence, scoring system, reproducibility and clinicopathological correlates. Am J Transplant 2008; 8: 819-825. (Pubitemid 351347749)
27. Bray RA, Gebel HM,. Strategies for human leukocyte antigen antibody detection. Curr Opin Organ Transplant 2009; 14: 392-397.
28. Archdeacon P, Chan M, Neuland C, et al. Summary of FDA antibody-mediated rejection workshop. Am J Transplant 2011; 11: 896-906.
29. Seemayer CA, Gaspert A, Nickeleit V, Mihatsch MJ,. C4d staining of renal allograft biopsies: A comparative analysis of different staining techniques. Nephrol Dial Transplant 2007; 22: 568-576. (Pubitemid 46189903)
30. Gaston RS, Cecka JM, Kasiske BL, et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure 1. Transplant 2010; 90: 68-74.
31. Mengel M, Sis B, Haas M, et al. Banff 2011 Meeting Report: New concepts in antibody-mediated rejection. Am J Transplant 2012; 12: 563-570.
32. Cardoso F, Van't VL, Rutgers E, Loi S, Mook S, Piccart-Gebhart MJ,. Clinical application of the 70-gene profile: The MINDACT trial. J Clin Oncol 2008; 26: 729-735. (Pubitemid 351264385)
33. Yang M, Rajan S, Issa AM,. Cost effectiveness of gene expression profiling for early stage breast cancer: A decision-analytic model. Cancer 2012; 118: 6298-6299.
34. Prat A, Parker JS, Fan C, et al. Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen. Ann Oncol 2012; 23: 2866-2867.
35. Hartmann S, Gerber B, Elling D, Heintze K, Reimer T,. The 70-gene signature as prognostic factor for elderly women with hormone receptor-positive, HER2-negative breast cancer. Breast Care 2012; 7: 19-24.
36. Limmathurotsakul D, Turner EL, Wuthiekanun V, et al. Fool's gold: Why imperfect reference tests are undermining the evaluation of novel diagnostics: A reevaluation of 5 diagnostic tests for leptospirosis. Clin Infect Dis 2012; 55: 322-331.
37. Reitsma JB, Rutjes AW, Khan KS, Coomarasamy A, Bossuyt PM,. A review of solutions for diagnostic accuracy studies with an imperfect or missing reference standard. J Clin Epidemiol 2009; 62: 797-806.
38. McAdam AJ,. Discrepant analysis: How can we test a test?. J Clin Microbiol 2000; 38: 2027-2029. (Pubitemid 30414310)
39. Reeve J, Einecke G, Mengel M, et al. Diagnosing rejection in renal transplants: A comparison of molecular- and histopathology-based approaches. Am J Transplant 2009; 9: 1802-1810.
40. Sis B, Jhangri G, Bunnag S, Allanach K, Kaplan B, Halloran PF,. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312-2323.
41. Hidalgo LG, Sis B, Sellares J, et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: Evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant 2010; 10: 1812-1822.
42. Halloran PF, de Freitas DG, Einecke G, et al. The molecular phenotype of kidney transplants. Am J Transplant 2010; 10: 2215-2222.
43. Hidalgo LG, Sellares J, Sis B, Mengel M, Chang J, Halloran PF,. Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies. Am J Transplant 2012; 12: 1180-1191.
44. Reeve J, Sellares J, Mengel M, et al. Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am J Transplant In press 2012.
45. Mueller TF, Einecke G, Reeve J, et al. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007; 7: 2712-2722. (Pubitemid 350045779)
46. Sis B, Mengel M, Haas M, et al. Banff "09 Meeting Report: Antibody mediated graft deterioration and implementation of Banff Working Groups. Am J Transplant 2010; 10: 464-471.
47. de Freitas DG, Sellares J, Mengel M, et al. The nature of biopsies with "Borderline Rejection" and prospects for eliminating this category. Am J Transplant 2012; 12: 191-201.
48. Famulski KS, de Freitas DG, Kreepala, et al. Molecular phenotypes of acute kidney injury in human kidney transplants. JASN 2012; 23: 948-958.
49. Mengel M, Reeve J, Bunnag S, et al. Molecular correlates of scarring in kidney transplants: The emergence of mast cell transcripts. Am J Transplant 2009; 9: 169-178.
50. Steyerberg EW,. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. 1st ed. New York: Springer Science+Business Media; 2009.
51. Torgo L,. Data Mining with R: Learning with Case Studies. 1st Ed. Voca Raton, FL: CRC Press, 2010.
52. Shi L, Campbell G, Jones WD, et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol 2010; 28: 827-838.
53. Kim JH,. Estimating classification error rate: Repeated cross-validation, repeated hold-out and bootstrap. Comput Stat Data Anal 2009; 53: 3735-3745.
54. Kashiwazaki M, Tanaka T, Kanda H, et al. A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions. Int Immunol 2003; 15: 1219-1227. (Pubitemid 37220495)
55. Fang Y, Davies PF,. Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium. Arterioscler Thromb Vasc Biol 2012; 32: 979-987.
56. Agresti A,. Categorical Data Analysis. 2nd Ed. New York: John Wiley & Sons; 2002.
57. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753-760. (Pubitemid 351347767)
58. Loupy A, Sellares J, Hidalgo L, Legendre C, Halloran PF,. Determinants of progression to transplant glomerulopathy in ABMR: A combined clinical-molecular approach. Am J Transplant 2012; 12: 44. Ref Type: Abstract.
59. Radaev S, Sun P,. Recognition of immunoglobulins by Fcgamma receptors. Mol Immunol 2002; 38: 1073-1083.
60. Ogawa K, Tanaka K, Ishii A, et al. A novel serum protein that is selectively produced by cytotoxic lymphocytes. J Immunol 2001; 166: 6404-6412. (Pubitemid 32440775)
61. Park WD, Grande JP, Ninova D, et al. Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant 2003; 3: 952-960. (Pubitemid 36917540)
62. Bach FH, Ferran C, Hechenleitner P, et al. Accommodation of vascularized xenografts: Expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 1997; 3: 196-204. (Pubitemid 27064705)
63. Mirnezami R, Nicholson J, Darzi A,. Preparing for precision medicine. N Engl J Med 2012; 366: 489-491.